Skip to main content

Table 1 Baseline characteristics in CKD (n = 136) and control (n = 33) groups.

From: Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients

Variables

CKD group

Control group

Age (years)

66.5 ± 14.3

74.8 ± 10.4

Males/females

66/70

13/20

Aetiology of CKD

  

   Diabetes

80 (58.8%)

-

   Hypertension

28 (20.6%)

-

   Chronic glomerulonephritis

7 (5.1%)

-

   Others/unknown

21 (15.4%)

-

BUN (mg/dL)

64.8 ± 34.9

22.2 ± 4.8

Serum Cr (mg/dL)

6.0 ± 4.1

0.9 ± 0.2

eGFR (ml/min/1.73 m2)

12.8 ± 7.3

71.4 ± 15.4

BNP (pg/mL)

1842.8 ± 1459.5

1418.9 ± 1126.5

Haemodialysis/peritoneal dialysis

47 (34.6%)/11 (8.1%)

 

Prior history

  

   Congestive heart failure

35 (25.7%)

7 (21.2%)

   Coronary artery disease

39 (28.7%)

9 (27.2%)

SAPS II

41.9 ± 13.4

29.7 ± 4.0

SOFA

5.8 ± 2.9

3.3 ± 3.2

Admission diagnosis

  

   ADHF

81 (59.6%)

33 (100%)

   Sepsis/infection

12 (8.8%)

-

   Gastrointestinal/liver

10 (7.4%)

-

   Neurological disease

7 (5.1%)

-

   Others

26 (19.1%)

-

  1. ADHF = acute decompensated heart failure; BNP = brain natriuretic peptide; BUN = blood urea nitrogen; CKD = chronic kidney disease; Cr = creatinine; eGFR = estimated glomerular filtration rate; SAPS II = simplified acute physiology score II; SOFA = sequential organ failure assessment.